| Stem definition | Drug id | CAS RN |
|---|---|---|
| 3874 | 6223-35-4 |
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Jan. 1, 1986 | YEAR INTRODUCED |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Hepatic function abnormal | 51.24 | 45.36 | 17 | 526 | 37125 | 63451354 |
None
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Hepatic function abnormal | 48.44 | 30.04 | 24 | 1335 | 73083 | 79669946 |
| Platelet count decreased | 44.15 | 30.04 | 32 | 1327 | 194632 | 79548397 |
| Interstitial lung disease | 36.21 | 30.04 | 23 | 1336 | 112577 | 79630452 |
| Malignant neoplasm progression | 32.26 | 30.04 | 23 | 1336 | 135967 | 79607062 |
None
None
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 2.25 | acidic |
None
None
None
| ID | Source |
|---|---|
| D02075 | KEGG_DRUG |
| CHEBI:135153 | CHEBI |
| CHEMBL1837010 | ChEMBL_ID |
| C035058 | MESH_SUPPLEMENTAL_RECORD_UI |
| 1630 | INN_ID |
| 19WSH095WP | UNII |
| C0900866 | UMLSCUI |
| 23669592 | PUBCHEM_CID |
None